Marston's PLC
OTC:MRTPY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Marston's PLC
OTC:MRTPY
|
UK |
|
Brainstorm Cell Therapeutics Inc
OTC:BCLI
|
US |
|
S
|
Softcen Co Ltd
KOSDAQ:032680
|
KR |
Wall St Price Targets
MRTPY Price Targets Summary
Marston's PLC
According to Wall Street analysts, the average 1-year price target for MRTPY is 12.92 USD with a low forecast of 10.39 USD and a high forecast of 14.96 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MRTPY's stock price target?
Price Target
12.92
USD
According to Wall Street analysts, the average 1-year price target for MRTPY is 12.92 USD with a low forecast of 10.39 USD and a high forecast of 14.96 USD.
What is the Revenue forecast for Marston's PLC?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 2%.
What is the Gross Profit forecast for Marston's PLC?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Marston's PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 3%.
What is the Pre-Tax Income forecast for Marston's PLC?
Projected CAGR
2%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 2%.
What is the Net Income forecast for Marston's PLC?
Projected CAGR
-1%
The compound annual growth rate for Net Income over the next 3 years is -1%.
